CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- 4 Planned sale Chief Commercial Officer sold 2,960 shares at an average $159.60 ($472,404)
- 4 Open-market sale Corcoran Nicholas sold 10,000 shares at $176.02 ($1,760,200)
- 4 Open-market sale President & CEO sold 45,000 shares at an average $173.24 ($7,795,600)
- 4 Planned sale President & CEO sold 8,625 shares at an average $169.73 ($1,463,919)
- 4 Open-market sale Ranganath Anil P. sold 4,992 shares at an average $149.81 ($747,838)
- 4 Open-market sale Director sold 20,000 shares at an average $159.33 ($3,186,536)
- 4 Planned sale Director sold 6,750 shares at an average $149.96 ($1,012,230)
- 4 Planned sale Chief Commercial Officer sold 2,958 shares at an average $156.77 ($463,727)
- 4 Planned sale President & CEO sold 8,625 shares at an average $145.17 ($1,252,051)
- 4 Planned sale Chief Commercial Officer sold 2,958 shares at an average $151.40 ($447,853)
- 4 Planned sale President & CEO sold 8,625 shares at an average $141.85 ($1,223,473)
- 4 Open-market sale Director sold 1,193 shares at $138.08 ($164,729)
- 4 Planned sale Chief Financial Officer sold 2,060 shares at $135.93 ($280,016)
- 4 Planned sale Chief Commercial Officer sold 2,960 shares at an average $133.10 ($393,986)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $141.40 ($2,828,025)
- 4 Open-market sale Director sold 1,193 shares at $141.65 ($168,988)
- 4 Grant or award Director acquired 732 shares (grant or award)
- 4 Grant or award Director acquired 732 shares (grant or award)
- 4 Grant or award Director acquired 732 shares (grant or award)
- 4 Grant or award Director acquired 732 shares (grant or award)
Page 4 of 18 · 358 filings